{
    "info": {
        "nct_id": "NCT05405387",
        "official_title": "A Randomized Phase 2 Trial Investigating the Impact of Budesonide Prophylaxis on Incidence of ≥ Grade 2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant",
        "inclusion_criteria": "* Subject aged ≥ 18 years.\n* History of histologically confirmed multiple myeloma and/or Plasma Cell Leukemia diagnosis undergoing ASCT who are determined to be fit by the investigator to undergo ASCT with melphalan 200 mg/m2 or melphalan 140 mg/m2 as conditioning.\n* Able to provide informed consent and willing to sign an approved consent form that conforms to federal and institutional guidelines.\n* Adequate organ function as defined as:\n\n  --Hepatic:\n  * Total Bilirubin ≤ 2 x institutional upper limit of normal (ULN).\n  * AST(SGOT)/ALT(SGPT) ≤ 5 × institutional ULN\n* For female subjects who have not undergone surgical sterilization: Negative pregnancy test or evidence of post-menopausal status. The post-menopausal status will be defined as having been amenorrheic for 12 months without an alternative medical cause. The following age-specific requirements apply:\n\n  * Women < 50 years of age:\n\n    * Amenorrheic for ≥ 12 months following cessation of exogenous hormonal treatments; and\n    * Luteinizing hormone and follicle-stimulating hormone levels in the post-menopausal range for the institution; or\n    * Underwent surgical sterilization (bilateral oophorectomy or hysterectomy).\n  * Women ≥ 50 years of age:\n\n    * Amenorrheic for 12 months or more following cessation of all exogenous hormonal treatments; or\n    * Had radiation-induced menopause with last menses >1 year ago; or\n    * Had chemotherapy-induced menopause with last menses >1 year ago; or\n    * Underwent surgical sterilization (bilateral oophorectomy, bilateral salpingectomy, or hysterectomy).\n\nInclusion Criteria required for Patients Enrolling in Safety Run-In Cohort only:\n\n-Patient must have at least 2.5 x 106 CD34 cells in reserve for use if engraftment is delayed\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Ongoing or current use of oral budesonide at the time of enrollment.\n* Receiving other investigational agents, unless deemed acceptable after consultation with the PI\n* Subjects with moderate or severe pre-existing hepatic impairment as classified according to the Child-Pugh system.\n* Prior history or current diagnosis of inflammatory bowel disease, microscopic colitis at baseline.\n* Prior history of receiving an allogenic stem cell transplant\n* Medical, psychiatric, cognitive, or other conditions that may compromise the subject's ability to understand the subject information, give informed consent, comply with the study protocol or complete the study.\n* Known prior severe hypersensitivity to melphalan or budesonide or any component in their formulations or compounds of similar composition (NCI CTCAE v5.0 Grade ≥ 3).\n* Subjects taking prohibited medications as described in Section 6.6.1. A washout period of prohibited medications for a period of at least five half-lives or 14 days (whichever is shorter) should occur before the start of treatment.",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Underwent surgical sterilization (bilateral oophorectomy or hysterectomy).",
            "criterions": [
                {
                    "exact_snippets": "Underwent surgical sterilization (bilateral oophorectomy or hysterectomy)",
                    "criterion": "surgical sterilization",
                    "requirements": [
                        {
                            "requirement_type": "procedure",
                            "expected_value": [
                                "bilateral oophorectomy",
                                "hysterectomy"
                            ]
                        },
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Amenorrheic for ≥ 12 months following cessation of exogenous hormonal treatments; and",
            "criterions": [
                {
                    "exact_snippets": "Amenorrheic for ≥ 12 months following cessation of exogenous hormonal treatments",
                    "criterion": "amenorrhea",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 12,
                                "unit": "months"
                            }
                        },
                        {
                            "requirement_type": "timing_context",
                            "expected_value": "following cessation of exogenous hormonal treatments"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Women < 50 years of age:",
            "criterions": [
                {
                    "exact_snippets": "Women < 50 years of age",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "sex",
                            "expected_value": "female"
                        },
                        {
                            "requirement_type": "age",
                            "expected_value": {
                                "operator": "<",
                                "value": 50,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Able to provide informed consent and willing to sign an approved consent form that conforms to federal and institutional guidelines.",
            "criterions": [
                {
                    "exact_snippets": "Able to provide informed consent",
                    "criterion": "informed consent capacity",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "willing to sign an approved consent form that conforms to federal and institutional guidelines",
                    "criterion": "consent form signing",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "form approval",
                            "expected_value": "conforms to federal and institutional guidelines"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Total Bilirubin ≤ 2 x institutional upper limit of normal (ULN).",
            "criterions": [
                {
                    "exact_snippets": "Total Bilirubin ≤ 2 x institutional upper limit of normal (ULN)",
                    "criterion": "total bilirubin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "x institutional upper limit of normal (ULN)"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Inclusion Criteria required for Patients Enrolling in Safety Run-In Cohort only:",
            "criterions": [
                {
                    "exact_snippets": "Inclusion Criteria required for Patients Enrolling in Safety Run-In Cohort only",
                    "criterion": "enrollment cohort",
                    "requirements": [
                        {
                            "requirement_type": "cohort type",
                            "expected_value": "Safety Run-In Cohort"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* AST(SGOT)/ALT(SGPT) ≤ 5 × institutional ULN",
            "criterions": [
                {
                    "exact_snippets": "AST(SGOT)/ALT(SGPT) ≤ 5 × institutional ULN",
                    "criterion": "AST (SGOT)",
                    "requirements": [
                        {
                            "requirement_type": "level",
                            "expected_value": {
                                "operator": "<=",
                                "value": 5,
                                "unit": "institutional ULN"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "AST(SGOT)/ALT(SGPT) ≤ 5 × institutional ULN",
                    "criterion": "ALT (SGPT)",
                    "requirements": [
                        {
                            "requirement_type": "level",
                            "expected_value": {
                                "operator": "<=",
                                "value": 5,
                                "unit": "institutional ULN"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Women ≥ 50 years of age:",
            "criterions": [
                {
                    "exact_snippets": "Women",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": "female"
                        }
                    ]
                },
                {
                    "exact_snippets": "≥ 50 years of age",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 50,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Had radiation-induced menopause with last menses >1 year ago; or",
            "criterions": [
                {
                    "exact_snippets": "Had radiation-induced menopause",
                    "criterion": "menopause",
                    "requirements": [
                        {
                            "requirement_type": "cause",
                            "expected_value": "radiation-induced"
                        }
                    ]
                },
                {
                    "exact_snippets": "last menses >1 year ago",
                    "criterion": "last menses",
                    "requirements": [
                        {
                            "requirement_type": "time since last menses",
                            "expected_value": {
                                "operator": ">",
                                "value": 1,
                                "unit": "year"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* For female subjects who have not undergone surgical sterilization: Negative pregnancy test or evidence of post-menopausal status. The post-menopausal status will be defined as having been amenorrheic for 12 months without an alternative medical cause. The following age-specific requirements apply:",
            "criterions": [
                {
                    "exact_snippets": "For female subjects who have not undergone surgical sterilization",
                    "criterion": "surgical sterilization status (female)",
                    "requirements": [
                        {
                            "requirement_type": "surgical sterilization",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "Negative pregnancy test",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "pregnancy test result",
                            "expected_value": "negative"
                        }
                    ]
                },
                {
                    "exact_snippets": "evidence of post-menopausal status ... defined as having been amenorrheic for 12 months without an alternative medical cause",
                    "criterion": "post-menopausal status",
                    "requirements": [
                        {
                            "requirement_type": "amenorrhea duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 12,
                                "unit": "months"
                            }
                        },
                        {
                            "requirement_type": "alternative medical cause for amenorrhea",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject aged ≥ 18 years.",
            "criterions": [
                {
                    "exact_snippets": "Subject aged ≥ 18 years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "age",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Amenorrheic for 12 months or more following cessation of all exogenous hormonal treatments; or",
            "criterions": [
                {
                    "exact_snippets": "Amenorrheic for 12 months or more following cessation of all exogenous hormonal treatments",
                    "criterion": "amenorrhea",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 12,
                                "unit": "months"
                            }
                        },
                        {
                            "requirement_type": "cause",
                            "expected_value": "following cessation of all exogenous hormonal treatments"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of histologically confirmed multiple myeloma and/or Plasma Cell Leukemia diagnosis undergoing ASCT who are determined to be fit by the investigator to undergo ASCT with melphalan 200 mg/m2 or melphalan 140 mg/m2 as conditioning.",
            "criterions": [
                {
                    "exact_snippets": "History of histologically confirmed multiple myeloma",
                    "criterion": "multiple myeloma",
                    "requirements": [
                        {
                            "requirement_type": "history of diagnosis",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "histological confirmation",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Plasma Cell Leukemia diagnosis",
                    "criterion": "plasma cell leukemia",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "undergoing ASCT",
                    "criterion": "autologous stem cell transplant (ASCT)",
                    "requirements": [
                        {
                            "requirement_type": "undergoing procedure",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "determined to be fit by the investigator to undergo ASCT",
                    "criterion": "fitness for ASCT",
                    "requirements": [
                        {
                            "requirement_type": "investigator assessment",
                            "expected_value": "fit"
                        }
                    ]
                },
                {
                    "exact_snippets": "melphalan 200 mg/m2 or melphalan 140 mg/m2 as conditioning",
                    "criterion": "melphalan conditioning regimen",
                    "requirements": [
                        {
                            "requirement_type": "conditioning regimen",
                            "expected_value": [
                                "melphalan 200 mg/m2",
                                "melphalan 140 mg/m2"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Had chemotherapy-induced menopause with last menses >1 year ago; or",
            "criterions": [
                {
                    "exact_snippets": "Had chemotherapy-induced menopause",
                    "criterion": "chemotherapy-induced menopause",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "last menses >1 year ago",
                    "criterion": "time since last menses",
                    "requirements": [
                        {
                            "requirement_type": "duration since last menses",
                            "expected_value": {
                                "operator": ">",
                                "value": 1,
                                "unit": "year"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Adequate organ function as defined as:",
            "criterions": [
                {
                    "exact_snippets": "Adequate organ function",
                    "criterion": "organ function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Luteinizing hormone and follicle-stimulating hormone levels in the post-menopausal range for the institution; or",
            "criterions": [
                {
                    "exact_snippets": "Luteinizing hormone ... levels in the post-menopausal range for the institution",
                    "criterion": "luteinizing hormone level",
                    "requirements": [
                        {
                            "requirement_type": "range",
                            "expected_value": "post-menopausal range for the institution"
                        }
                    ]
                },
                {
                    "exact_snippets": "follicle-stimulating hormone levels in the post-menopausal range for the institution",
                    "criterion": "follicle-stimulating hormone level",
                    "requirements": [
                        {
                            "requirement_type": "range",
                            "expected_value": "post-menopausal range for the institution"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Underwent surgical sterilization (bilateral oophorectomy, bilateral salpingectomy, or hysterectomy).",
            "criterions": [
                {
                    "exact_snippets": "Underwent surgical sterilization (bilateral oophorectomy, bilateral salpingectomy, or hysterectomy)",
                    "criterion": "surgical sterilization",
                    "requirements": [
                        {
                            "requirement_type": "procedure",
                            "expected_value": [
                                "bilateral oophorectomy",
                                "bilateral salpingectomy",
                                "hysterectomy"
                            ]
                        },
                        {
                            "requirement_type": "status",
                            "expected_value": "underwent"
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Prior history or current diagnosis of inflammatory bowel disease, microscopic colitis at baseline.",
            "criterions": [
                {
                    "exact_snippets": "Prior history or current diagnosis of inflammatory bowel disease",
                    "criterion": "inflammatory bowel disease",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "current diagnosis",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "microscopic colitis at baseline",
                    "criterion": "microscopic colitis",
                    "requirements": [
                        {
                            "requirement_type": "presence at baseline",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects taking prohibited medications as described in Section 6.6.1. A washout period of prohibited medications for a period of at least five half-lives or 14 days (whichever is shorter) should occur before the start of treatment.",
            "criterions": [
                {
                    "exact_snippets": "Subjects taking prohibited medications as described in Section 6.6.1.",
                    "criterion": "use of prohibited medications",
                    "requirements": [
                        {
                            "requirement_type": "absence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "A washout period of prohibited medications for a period of at least five half-lives or 14 days (whichever is shorter) should occur before the start of treatment.",
                    "criterion": "washout period for prohibited medications",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 5,
                                        "unit": "half-lives"
                                    },
                                    {
                                        "operator": ">=",
                                        "value": 14,
                                        "unit": "days"
                                    }
                                ]
                            }
                        },
                        {
                            "requirement_type": "selection",
                            "expected_value": "whichever is shorter"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prior history of receiving an allogenic stem cell transplant",
            "criterions": [
                {
                    "exact_snippets": "Prior history of receiving an allogenic stem cell transplant",
                    "criterion": "allogenic stem cell transplant",
                    "requirements": [
                        {
                            "requirement_type": "prior history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Ongoing or current use of oral budesonide at the time of enrollment.",
            "criterions": [
                {
                    "exact_snippets": "Ongoing or current use of oral budesonide at the time of enrollment.",
                    "criterion": "oral budesonide use",
                    "requirements": [
                        {
                            "requirement_type": "use status",
                            "expected_value": [
                                "ongoing",
                                "current"
                            ]
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "at the time of enrollment"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects with moderate or severe pre-existing hepatic impairment as classified according to the Child-Pugh system.",
            "criterions": [
                {
                    "exact_snippets": "moderate or severe pre-existing hepatic impairment as classified according to the Child-Pugh system",
                    "criterion": "hepatic impairment",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": [
                                "moderate",
                                "severe"
                            ]
                        },
                        {
                            "requirement_type": "classification_system",
                            "expected_value": "Child-Pugh"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Medical, psychiatric, cognitive, or other conditions that may compromise the subject's ability to understand the subject information, give informed consent, comply with the study protocol or complete the study.",
            "criterions": [
                {
                    "exact_snippets": "Medical, psychiatric, cognitive, or other conditions that may compromise the subject's ability to understand the subject information",
                    "criterion": "medical, psychiatric, cognitive, or other conditions",
                    "requirements": [
                        {
                            "requirement_type": "impact on ability to understand subject information",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "Medical, psychiatric, cognitive, or other conditions that may compromise the subject's ability to ... give informed consent",
                    "criterion": "medical, psychiatric, cognitive, or other conditions",
                    "requirements": [
                        {
                            "requirement_type": "impact on ability to give informed consent",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "Medical, psychiatric, cognitive, or other conditions that may compromise the subject's ability to ... comply with the study protocol",
                    "criterion": "medical, psychiatric, cognitive, or other conditions",
                    "requirements": [
                        {
                            "requirement_type": "impact on ability to comply with the study protocol",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "Medical, psychiatric, cognitive, or other conditions that may compromise the subject's ability to ... complete the study",
                    "criterion": "medical, psychiatric, cognitive, or other conditions",
                    "requirements": [
                        {
                            "requirement_type": "impact on ability to complete the study",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Known prior severe hypersensitivity to melphalan or budesonide or any component in their formulations or compounds of similar composition (NCI CTCAE v5.0 Grade ≥ 3).",
            "criterions": [
                {
                    "exact_snippets": "Known prior severe hypersensitivity to melphalan",
                    "criterion": "hypersensitivity to melphalan",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "NCI CTCAE v5.0 Grade"
                            }
                        },
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Known prior severe hypersensitivity to ... budesonide",
                    "criterion": "hypersensitivity to budesonide",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "NCI CTCAE v5.0 Grade"
                            }
                        },
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Known prior severe hypersensitivity to ... any component in their formulations",
                    "criterion": "hypersensitivity to any component in melphalan or budesonide formulations",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "NCI CTCAE v5.0 Grade"
                            }
                        },
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Known prior severe hypersensitivity to ... compounds of similar composition",
                    "criterion": "hypersensitivity to compounds of similar composition to melphalan or budesonide",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "NCI CTCAE v5.0 Grade"
                            }
                        },
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Receiving other investigational agents, unless deemed acceptable after consultation with the PI",
            "criterions": [
                {
                    "exact_snippets": "Receiving other investigational agents",
                    "criterion": "receipt of other investigational agents",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "unless deemed acceptable after consultation with the PI",
                    "criterion": "PI consultation and approval for investigational agents",
                    "requirements": [
                        {
                            "requirement_type": "approval",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [
        {
            "line": "--Hepatic:",
            "criterions": []
        },
        {
            "line": "-Patient must have at least 2.5 x 106 CD34 cells in reserve for use if engraftment is delayed",
            "criterions": [
                {
                    "exact_snippets": "at least 2.5 x 10^6 CD34 cells in reserve",
                    "criterion": "CD34 cells in reserve",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2500000.0,
                                "unit": ""
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}